Monday 20 October 2014

FDA Panel Backs Novel Biologic for Psoriasis

(MedPage Today) -- IL-17a inhibitor secukinumab wins plaudits from outside advisers. via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)